Suzhou MedicalSystem Technology Co., Ltd. Stock

Equities

603990

CNE100002ZY8

Advanced Medical Equipment & Technology

End-of-day quote Shanghai S.E. 06:00:00 2024-04-18 pm EDT 5-day change 1st Jan Change
9.18 CNY -0.22% Intraday chart for Suzhou MedicalSystem Technology Co., Ltd. -12.49% -28.95%
Sales 2023 * 949M 131M Sales 2024 * 3.91B 540M Capitalization 2.78B 385M
Net income 2023 * -96M -13.26M Net income 2024 * 201M 27.76M EV / Sales 2023 * 2.93 x
Net cash position 2023 * - 0 Net cash position 2024 * - 0 EV / Sales 2024 * 0.71 x
P/E ratio 2023 *
-29.6 x
P/E ratio 2024 *
13.9 x
Employees 723
Yield 2023 *
-
Yield 2024 *
-
Free-Float 65.62%
More Fundamentals * Assessed data
Dynamic Chart
Tranche Update on Suzhou MedicalSystem Technology Co., Ltd.'s Equity Buyback Plan announced on February 7, 2024. CI
Suzhou MedicalSystem Technology Co., Ltd. announces an Equity Buyback for CNY 30 million worth of its shares. CI
Suzhou MedicalSystem Technology Co., Ltd. authorizes a Buyback Plan. CI
Suzhou MedicalSystem Signs 3 Billion Yuan Photovoltaic Cells Supply Contract MT
Suzhou MedicalSystem Technology Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2023 CI
Suzhou MedicalSystem Unit Signs 2 Billion Yuan Silicon Wafer Purchase Deal; Shares Climb 3% MT
Suzhou MedicalSystem Technology Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2023 CI
Bioalpha, Suzhou Medicalsystem Inject MYR10 Million into JV Firm MT
Suzhou MedicalSystem Technology Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2022 CI
Suzhou MedicalSystem Technology Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2023 CI
Suzhou MedicalSystem Technology Co., Ltd. announced that it has received CNY 238.843093 million in funding from Mianyang Haoxiang Holdings Co., Ltd CI
Suzhou MedicalSystem Technology Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2022 CI
Suzhou MedicalSystem Technology Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2022 CI
Mianyang Haoxiang Holdings Co., Ltd completed the acquisition of a 7.66% stake in Suzhou MedicalSystem Technology Co., Ltd. from Weng Kang, Yan Huanghong, Wang Jianhua and Fu Hong for approximately CNY 340 million. CI
Mianyang Haoxiang Holdings Co., Ltd agreed to acquire a 7.63% stake in Suzhou MedicalSystem Technology Co., Ltd. from Weng Kang, Yan Huanghong, Wang Jianhua and Fu Hong for approximately CNY 340 million. CI
More news
1 day-0.22%
1 week-12.49%
Current month-15.47%
1 month-23.12%
3 months-20.31%
6 months-31.54%
Current year-28.95%
More quotes
1 week
8.80
Extreme 8.8
10.14
1 month
8.80
Extreme 8.8
12.52
Current year
8.12
Extreme 8.12
12.91
1 year
8.12
Extreme 8.12
19.33
3 years
8.04
Extreme 8.0355
26.46
5 years
8.04
Extreme 8.0355
33.11
10 years
4.54
Extreme 4.5354
33.11
More quotes
Managers TitleAgeSince
Chief Executive Officer 56 23-01-08
Chief Executive Officer 56 15-07-31
Director of Finance/CFO 57 22-12-29
Members of the board TitleAgeSince
Director/Board Member 63 23-01-08
Chief Executive Officer 56 15-07-31
Director/Board Member 47 19-05-05
More insiders
Date Price Change Volume
24-04-18 9.18 -0.22% 4 977 851
24-04-18 9.2 -2.34% 5,598,066
24-04-17 9.42 +6.68% 6,678,774
24-04-16 8.83 -7.92% 7,988,563
24-04-15 9.59 -4.20% 7,984,031

End-of-day quote Shanghai S.E., April 18, 2024

More quotes
Suzhou Medical System Techology Co Ltd is a company mainly engaged in development and sales of clinical medical management information system software products. The Company's products include two types. The DoCare series of clinical medical management information system application software mainly includes anesthesia clinical information system, intensive care clinical information system, pre-hospital emergency information system, blood purification information system and clinical path information system. Another type of products is the overall solution of clinical information, including the overall solution of Dorico digital operating room and the overall solution of Dorico digital emergency first aid platform.
Calendar
More about the company
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
1
Last Close Price
9.18
Average target price
-
Consensus

Annual profits - Rate of surprise

  1. Stock Market
  2. Equities
  3. 603990 Stock